Phospholipase C from Clostridium perfringens Stimulates Acetyltransferase-Dependent Formation of Platelet-Activating Factor in Cultured Intestinal Epithelial Cells (INT 407)

References

• Braquet P, Vargaftig B B. Pharmacology of platelet-activating factor. Transplant Proc 1986; 28: 10–9
   Google Scholar
• Wallace J L., Steel G, Whittle B JR, Lagente V, Vargaftig B. Evidence for platelet-activating factor as a mediator of endo-toxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology 1987; 93: 765–73
   PubMed Web of Science ®Google Scholar
• Rosam A-C, Wallace J L. Potent ulcerogenic actions of platelet-activating factor the stomach. Nature 1986; 319: 54–6
   PubMed Web of Science ®Google Scholar
• Boughton-Smith N K., Wallace J L., Morris G P., Whittle B JR. The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol 1988; 94: 65–72
   PubMed Web of Science ®Google Scholar
• Eliakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Gastroenterology 1988; 95: 1167–72
   PubMed Web of Science ®Google Scholar
• Kald B, Olaison G, Sjodahl R, Tagesson C. Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa. Digestion 1990; 46: 199–204
   PubMed Web of Science ®Google Scholar
• Denizot Y, Chaussade S, Nathan N, Colombel J F., Bossant M-J, Cherouki N, et al. PAF-acether and acethylhydrolase in stool of patients with Crohn's disease. Dig Dis Sci 1992; 37: 432–7
   PubMed Web of Science ®Google Scholar
• Gustafson C, Kald B, Sjödahl R, Tagesson C. Phospholipase C from Clostridium perfringens stimulates formation and release of platelet-activating factor (PAF-acether) in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 1991; 26: 1000–6
   PubMed Web of Science ®Google Scholar
• Hill J M. Microbial metabolism in the digestive tract. CRC Press Inc, Boca Raton, FL 1986
   Google Scholar
• Olhagen B. Intestinal Clostridium perfringens in arthritis and allied conditions. Infection and immunology in the rheumatic diseases, D C. Dumonde. Blackwell Scientific Publications, Oxford 1976
   Google Scholar
• Olhagen B, Månsson I. Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases. Acta Med Scand 1968; 184: 395–402
   PubMedGoogle Scholar
• Månsson I, Norberg R, Olhagen B, Bjårklund N-E. Arthritis in pigs induced by dietary factors. Microbiologic, clinical and histologic studies. Clin Exp Immunol 1971; 9: 677–93
   PubMed Web of Science ®Google Scholar
• Henle G. Deinhardt F. The establishment of strains of human cells in tissue culture. J Immunol 1957; 79: 54–9
   PubMed Web of Science ®Google Scholar
• Yada T, Okada Y. Electrical activity of an intestinal epithelial cell line: hyperpolarizing responses to intestinal secretagogues. J Membrane Biol 1984; 77: 33–44
   PubMed Web of Science ®Google Scholar
• Gustafson C, Tagesson C. Phospholipase activation and arachi-donic acid release in cultured intestinal epithelial cells. Scand J Gastroenterol 1989; 24: 475–84
   PubMed Web of Science ®Google Scholar
• Gustafson C, Tagesson C. Phospholipase C from Clostridium perfringens stimulates phospholipase A2-mediated arachidonic acid release in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 1990; 25: 363–71
   PubMed Web of Science ®Google Scholar
• Bligh E G., Dyer W J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911–7
   PubMedGoogle Scholar
• Nakamura T., Morita Y, Ishihara M., Kuriyama K, Ito K, Miyamoto T. Platelet-activating factor in late asthmatic response. Int Arch Allergy Appl Immunol 1987; 82: 57–61
   PubMedGoogle Scholar
• Snyder F. Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids. Proc Soc Exp Biol Med 1989; 190: 125–35
   PubMed Web of Science ®Google Scholar
• Waite M. The phospholipases. Plenum Press, New York 1987; 332, (Hanahan DJ, editor. Handbook of lipid research; vol 5)
   Google Scholar
• Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984; 308: 693–8
   PubMed Web of Science ®Google Scholar
• Touqui L, Rothhut B, Shaw A M., Fradin A, Vargaftig B B., Russo-Marie F. Platelet activation–a role for a 40 kD anti-phospholipase A2 protein indistinguishable from lipocortin. Nature 1986; 321: 177–80
   PubMed Web of Science ®Google Scholar
• Snyder F. Platelet-activating factor and related lipid mediators. Plenum Press, New York 1987
   Google Scholar
• Billah M M., Siegel M I. Calmodulin antagonists inhibit formation of platelet-activating factor in stimulated human neutrophils. Biochem Biophys Res Commun 1984; 118: 629–53
   PubMed Web of Science ®Google Scholar
• Ballou L RYCW. Marked increase of human platelet phospholipase A2 activity and demonstration of an endogenous inhibitor. Proc Natl Acad Sci USA 1983; 809: 5203–7-
   Google Scholar
• Kao K-J, Sommer J R., Pizzo S V. Modulation of platelet shape and membrane receptor binding by Ca2+-calmodulin complex. Nature 1981; 292: 82–A
   PubMed Web of Science ®Google Scholar
• Massom L, Lee H, Jarrett H W. Trifluoperazine binding to porcine brain calmodulin and skeletal muscle troponin. Biochemistry 1990; 29: 671–81
   PubMed Web of Science ®Google Scholar
• Froscio M, Guy G R., Murray A W. Calmodulin inhibitors modify cell surface changes triggered by a tumor promotor. Biochem Biophys Res Commun 1981; 98: 829–35
   PubMed Web of Science ®Google Scholar
• Schatzman R C., Wise B C., Kuo J F. Phospholipid-sensitive calcium-dependent protein kinase: inhibition by anti-psychotic drugs. Biochem Biophys Res Commun 1981; 98: 669–76
   PubMed Web of Science ®Google Scholar
• Capdevila J, Gil L, Orellana M, Marnett L WJ, Mason I, Yadagri P, et al. Inhibitors of p-450 dependent arachidonic acid metabolism. Arch Biochem Biophys 1988; 261: 257–63
   PubMed Web of Science ®Google Scholar
• Nakadate T. The mechanism of skin tumor promotion caused by phorbol esters: possible involvement of arachidonic acid cascade/lipoxygenase, protein kinase C and cakium/modulin systems. Jpn J Pharmacol 1989; 49: 1–9
   PubMedGoogle Scholar
• Lindahl M, Bruhn R, Tagesson C. Lysophosphatidylcholine and the inflammatory action of neutrophils. Scand J Clin Lab Invest 1988; 48: 303–11
   PubMed Web of Science ®Google Scholar
• Sobhani I, Hochlaf S, Denizot Y, Vissuzaine C, Rene E, Benveniste J, et al. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut 1992; 33: 1220–5
   PubMed Web of Science ®Google Scholar